Company Mymetics Corp OTC Bulletin Board
Equities
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
Business Summary
Sales per Business
USD in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
Grants
99.7
%
| 1 | 99.3 % | 1 | 99.7 % | +113.44% |
Sales Other
0.3
%
| - | - | 0 | 0.3 % | - |
Sales per region
USD in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
European Union and United States
100.0
%
| 1 | 100.0 % | 1 | 100.0 % | +112.57% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 56 | 30/06/09 | |
Mario Amacker
PRN | Corporate Officer/Principal | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Thomas Staehelin
BRD | Director/Board Member | 76 | 01/07/07 |
Ulrich Burkhard
BRD | Director/Board Member | 63 | 22/03/12 |
Marcel B. Rüegg
BRD | Director/Board Member | - | 15/01/23 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 151,879 | 73,993 ( 48.72 %) | 0 | 48.72 % |
Company contact information
Sector
Sales per Business
1st Jan change | Capi. | |
---|---|---|
+16.63% | 122B | |
+20.11% | 115B | |
+21.22% | 26.64B | |
-23.56% | 19.91B | |
-17.47% | 16.32B | |
-45.95% | 15.52B | |
-18.60% | 15.49B | |
+62.01% | 14.83B | |
+2.72% | 13.67B |
- Stock Market
- Equities
- MYMX Stock
- Stock
- Company Mymetics Corp